Unlock instant, AI-driven research and patent intelligence for your innovation.

Nano antibody for type A H3N2 influenza virus and application thereof

A nano-antibody, H3N2 technology, applied in the field of biomedicine or biopharmaceuticals, can solve problems such as high cost and time-consuming

Active Publication Date: 2014-04-30
北京科卫临床诊断试剂有限公司
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, before synthesizing monoclonal antibodies, it is usually necessary to isolate antibodies from mice, and then perform complex humanization operations and use bioreactors for preparation, which is time-consuming and expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nano antibody for type A H3N2 influenza virus and application thereof
  • Nano antibody for type A H3N2 influenza virus and application thereof
  • Nano antibody for type A H3N2 influenza virus and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Example 1: Construction of H3N2 Nanobody Library:

[0055] (1) Mix 0.1 mg of inactivated natural influenza A H3N2 antigen with an equal volume of Freund's adjuvant to immunize a Xinjiang Bactrian camel once a week for a total of 7 times to stimulate B cells to express antigen-specific nano Antibody; (2) After 7 times of immunization, extract 100 mL camel peripheral blood lymphocytes and extract total RNA; (3) Synthesize cDNA and amplify VHH by nested PCR; (4) Use restriction enzymes PstI and NotI Digest 20 ug pComb3 phage display vector (supplied by Biovector) and 10 ug VHH and ligate the two fragments; (5) Transform the ligated product into electroporation-competent cells TG1, construct the H3N2 nanobody library and measure the library capacity, the library size is 1.0 ×10 9 . At the same time, we randomly selected 24 clones for colony PCR detection, and the results showed that the insertion rate of the built library was above 90%. figure 1 Colony PCR results are...

Embodiment 2

[0056] Example 2: Nanobody screening process against H3N2:

[0057] (1) Dissolve in 100 mM NaHCO 3 , 20 ug of inactivated H3N2 antigen in pH 8.2 was coupled to the NUNC microtiter plate, and placed overnight at 4 ℃; (2) the next day, 100 uL of 0.1% casein was added, and blocked at room temperature for 2 h; (3) after 2 h , add 100 uL phage (5×10 11 tfu immunized camel nanobody phage display gene library), and reacted at room temperature for 1 h; (4) Washed 5 times with 0.05% PBS+Tween-20 to wash away non-specific phage; (5) Washed with 100 mM TEA (triethylamine) Dissociate the phage that specifically binds to H3N2, and infect Escherichia coli TG1 cells in logarithmic phase growth, culture at 37°C for 1 h, produce and purify the phage for the next round of screening, and repeat the same screening process for 3-4 Rounds, gradually enriched.

Embodiment 3

[0058] Example 3: Using phage enzyme-linked immunosorbent method (ELISA) to screen specific single positive clones:

[0059] (1) From the cell culture dish containing phage after the above 3-4 rounds of selection, pick 96 single colonies and inoculate them in TB medium containing 100 micrograms per milliliter of ampicillin (1 liter of TB medium contains 2.3 grams of phosphoric acid Potassium dihydrogen, 12.52 grams of dipotassium hydrogen phosphate, 12 grams of peptone, 24 grams of yeast extract, 4 milliliters of glycerol), after growing to the logarithmic phase, add IPTG with a final concentration of 1 millimolar, and culture overnight at 28 °C. (2) Use the infiltration method to obtain the crudely extracted antibody, and transfer the antibody to an antigen-coated ELISA plate, and place it at room temperature for 1 hour. (3) Wash off the unbound antibody with PBST, add a mouse anti-HA tag antibody (anti-mouse anti-HA antibody, purchased from Beijing Kangwei Century Biotech...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a nano antibody for type A H3N2 influenza virus epitope and a gene sequence for encoding the nano antibody, and further discloses a host cell for expressing the nano antibody and application of the host cell to diagnosis and treatment. By adopting the nano gene antibody gene sequence and the host cell disclosed by the invention, the nano antibody can be efficiently expressed in escherichia coli, and can be applied to development, targeted therapy and the like of a type A H3N2 influenza virus diagnosis kit.

Description

technical field [0001] The invention belongs to the technical field of biomedicine or biopharmaceuticals, and relates to a nanobody against influenza A H3N2 virus, its coding sequence and its application in diagnosis and treatment. Background technique [0002] Influenza viruses can be divided into three types: A, B, and C according to the antigenicity of the nucleoprotein. Influenza A viruses often appear in the form of epidemics and can cause a worldwide influenza pandemic; Influenza B viruses often cause local outbreaks and do not cause a pandemic of influenza worldwide; Influenza C viruses mainly appear in scattered forms and mainly attack infants and young children. Generally do not cause popular. Influenza A virus has the broadest host spectrum, including humans, pigs, horses, poultry, dogs and other animals. Influenza A virus can be divided into 16 subtypes (H1-H16) according to the difference of the hemagglutinin (HA) antigen on its surface, and 9 subtypes (N1) acc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/10C12N15/13C12N15/63G01N33/569
Inventor 万亚坤欧卫军朱敏孙燕燕
Owner 北京科卫临床诊断试剂有限公司